Skip to main content

7 Best Safe Stocks to Buy Now

Amid recent market volatility, many investors are looking for safe stocks. These solid investments have what it takes to deliver in any market environment.

[Sign up for stock news with our Invested newsletter.]

There’s no universal formula for picking these kinds of low-risk winners. But a few factors to consider include reliable cash flow, strong balance sheets and a proven commitment to returning capital to shareholders.

The following seven stocks all are big brands with massive market values, along with dividends that are 2% or higher. They represent stable companies that are among the safest stocks to buy now:

Stock Sector Market cap Dividend yield
Altria Group Inc. (ticker: MO) Consumer staples $112 billion 6.4%
Coca-Cola Co. (KO) Consumer staples $342 billion 2.6%
Duke Energy Corp. (DUK) Utilities $97 billion 3.4%
GSK PLC (GSK) Health care $124 billion 2.9%
JPMorgan Chase & Co. (JPM) Financial $846 billion 2.0%
Lockheed Martin Corp. (LMT) Industrials $152 billion 2.1%
Verizon Communications Inc. (VZ) Communication services $204 billion 5.8%

Altria Group Inc. (MO)

Sector: Consumer staples Market value: $112 billion Dividend yield: 6.4%

A favorite among dividend investors, tobacco giant Altria offers one of the highest yields available among large-cap U.S. stocks, along with unrivaled operational stability thanks to addictive products that generate strong sales in any economic environment. Best known for brands such as Marlboro cigarettes and Skoal smokeless tobacco, the company produces predictable cash flow that has allowed Altria to raise its dividend for more than 56 consecutive years. Shares have climbed roughly 34% over the past year, demonstrating that price appreciation can accompany a generous payout.

Coca-Cola Co. (KO)

Sector: Consumer staples Market value: $342 billion Dividend yield: 2.6%

Coca-Cola is one of the most recognizable brands in the world, and it remains a top dividend stock thanks to stable operations across economic cycles. Its product portfolio includes Coca-Cola, Gatorade and Minute Maid beverages, allowing Coca-Cola to compete across categories and geographies. The company has operated for more than 130 years and has increased its dividend for over six decades — a track record that is nearly unmatched on Wall Street. While growth is more modest than that of high-flying tech stocks, Coca-Cola’s ability to generate reliable cash flow and consistently return it to shareholders makes it a gold standard for dividend investors.

Duke Energy Corp. (DUK)

Sector:

Utilities Market value: $97 billion Dividend yield: 3.4%

Duke Energy stands out for its scale and dominance. Among the largest publicly traded utilities in the world, North Carolina-based Duke serves nearly 10 million electric and natural gas customers across the Southeast and Midwest. This scale alone makes DUK a compelling holding, but the company’s ongoing investment plans further strengthen the case. In 2025, the company boosted its five-year capital expenditure outlook to $83 billion — about 14% above prior estimates — to accommodate rising demand driven by the tech sector and population growth. This expansion underscores that Duke is not just a traditional utility, but a long-term infrastructure leader.

GSK PLC (GSK)

Sector: Health care Market value: $124 billion Dividend yield: 2.9%

With roots tracing back to 1715, U.K.-based pharmaceutical company GSK — previously known as GlaxoSmithKline — is a leader in respiratory, immunology and inflammation treatments. Its portfolio includes vaccines for shingles, meningitis and influenza, as well as leading asthma and HIV therapies. Health care remains one of the most resilient industries, with demand that holds steady across economic environments. Following strong share momentum, including gains of roughly 76% over the past 12 months, GSK offers an above-average dividend combined with defensive stability, making it an attractive income-oriented health care stock.

[Read: 7 Best Weight Loss Drug Stocks to Buy in 2026]

JPMorgan Chase & Co. (JPM)

Sector: Financials Market value: $846 billion Dividend yield: 2%

With roots tracing back to 1799, JPMorgan Chase has long been a leader in the banking industry and has a strong history of returning capital to shareholders through dividends. After regulators required major financial institutions to cut dividends during the 2009 financial crisis, JPM was among the first to restore its payout to pre-crisis levels by 2013. Since then, the quarterly dividend has risen from $0.38 to $1.50 — an increase of roughly 290%. With a payout ratio of less than one-third of projected earnings, the dividend appears well supported and positioned for further growth. As the largest U.S. bank by deposits, JPMorgan remains one of the most established and reliable financial stocks available.

Lockheed Martin Corp. (LMT)

Sector: Industrials Market value: $152 billion Dividend yield: 2.1%

Aerospace and defense giant Lockheed Martin has long been a leader in the global defense industry, including innovations such as the F-117 stealth fighter. Ongoing geopolitical tensions reinforce the strategic importance of defense contractors like LMT. Beyond near-term headlines, the company offers a strong long-term dividend record, with a quarterly payout of $3.45 — more than double its 2016 level. Lockheed’s deep government relationships and technical expertise provide durable competitive advantages and long-term revenue visibility.

Verizon Communications Inc. (VZ)

Sector: Communication services Market value: $204 billion Dividend yield: 5.8%

Verizon is one of the largest wireless providers in the U.S., serving nearly 150 million customers. Its massive scale generates consistent cash flow, supporting one of the most generous dividends among blue-chip stocks. While significant network investments have contributed to elevated debt levels, easing interest-rate conditions should improve financial flexibility. With dividends consuming less than 60% of earnings, Verizon remains a one of the best safe stocks to buy for an increasingly data-driven world.

More from U.S. News

9 Best Growth Stocks for the Next 10 Years

7 of the Best Growth Funds to Buy and Hold

6 Best Small-Cap Growth Stocks to Buy Now

7 Best Safe Stocks to Buy Now originally appeared on usnews.com

Update 02/18/26: This story was previously published at an earlier date and has been updated with new information.

Map shows more than 2,200 measles cases across U.S. in 2025 outbreaks

▶ Watch Video: Measles cases climb in the U.S. after 2025 was worst year in decades In 2025, United States recorded the most measles cases in more than 30 years, Centers for Disease Control and Prevention data shows. A large share of the infections were connected to an outbreak in West Texas that led to the deaths of two children. The total number of cases nationwide topped 2.200 by the end of the year, with infections confirmed in at least 44 states. Measles is one of the most contagious infectious diseases, and in some cases, can cause severe infections in the lungs and brain that can lead to cognitive issues, deafness or death. But doctors and health officials say the vaccine, which is normally given as part of the combination measles-mumps-rubella (MMR) vaccine, is highly safe and effective.While most people's symptoms improve, about 1 in 5 unvaccinated people who get measles will be hospitalized. About 1 out of every 1,000 children with measles will develop brain swelling that can lead to brain damage, and up to 3 of every 1,000 children who become infected will die, the CDC says. The largest outbreak of the year was in West Texas, with over 760 confirmed infections before the state declared the outbreak officially over in August. A growing number of cases have also been reported in other states around the country. In South Carolina, dozens of students were quarantined in October due to an outbreak and the number of cases there ballooned to over 200 by the end of the year.The CBS News data team has tracked confirmed measles cases nationwide as new data is released by state health departments and the CDC. The Texas outbreak primarily affected children and teenagers, nearly all of whom were unvaccinated or had an unknown vaccination status. State and local health officials confirmed the first patient who died was an unvaccinated school-aged child, and the second was an unvaccinated 8-year-old girl. Neither of the children had underlying health conditions, the Texas health department said. New Mexico also reported the death of an adult with measles.The last measles death in the U.S. before that was in 2019, when a 37-year-old man died from measles complicated by meningitis in California, according to CDC data.Prior to 2025, the highest number of confirmed cases in the U.S. in recent years was 1,274 in 2019, driven by outbreaks in New York, California and Washington state, but most years the total has been much lower. Health experts point to lower vaccination rates as a reason for increases in preventable diseases like the measles.CDC data shows about 93% of kindergarteners in the U.S. were vaccinated against measles during the 2021-2022 school year and only 92.7% in the 2023-2024 school year. This is down from 95.2% during the 2019-2020 school year — a critical threshold to keep people safe. "When more than 95% of people in a community are vaccinated, most people are protected through community immunity (herd immunity)," the CDC states.Health and Human Services Secretary Robert F. Kennedy Jr., who has a history of making false and misleading claims about vaccines, voiced support for vaccination as the deadly outbreak spread in the Southwest."We encourage people to get the measles vaccine," Kennedy told CBS News chief medical correspondent Dr. Jon LaPook in an interview in April, marking the first time Kennedy has publicly urged people to get the measles vaccine since becoming HHS secretary.Asked by LaPook what the federal government's official position on the vaccine is, Kennedy reiterated, "The federal government's position, my position, is that people should get the measles vaccine," but added, "The government should not be mandating those." 
Read Next Story